Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-28T02:11:47.674Z Has data issue: false hasContentIssue false
  • English
  • Français

Modélisation de la décorporation du Pu/am par le dtpa

Published online by Cambridge University Press:  09 December 2009

P. Fritsch ,
A.-L. Sérandour ,
O. Grémy ,
B. Le Gall ,
G. Phan ,
N. Tsapis ,
E. Fattal ,
H. Benech ,
J.-R. Deverre  and
N. Blanchin
...Show all authors
P. Fritsch
Affiliation:
Laboratoire de Radiotoxicologie, CEA/DSV/iRCM/SREIT, BP 12, 91680 Bruyères-le-Châtel, France.
A.-L. Sérandour
Affiliation:
Laboratoire de Radiotoxicologie, CEA/DSV/iRCM/SREIT, BP 12, 91680 Bruyères-le-Châtel, France.
O. Grémy
Affiliation:
Laboratoire de Radiotoxicologie, CEA/DSV/iRCM/SREIT, BP 12, 91680 Bruyères-le-Châtel, France.
B. Le Gall
Affiliation:
Laboratoire de Radiotoxicologie, CEA/DSV/iRCM/SREIT, BP 12, 91680 Bruyères-le-Châtel, France.
G. Phan
Affiliation:
CEA/DSV/iBITEC/SPI, 91191 Gif-sur-Yvette, France.
N. Tsapis
Affiliation:
Université Paris-Sud, UMR CNRS 8612, 92296 Châtenay-Malabry, France.
E. Fattal
Affiliation:
Université Paris-Sud, UMR CNRS 8612, 92296 Châtenay-Malabry, France.
H. Benech
Affiliation:
CEA/DSV/iBITEC/SPI, 91191 Gif-sur-Yvette, France.
J.-R. Deverre
Affiliation:
CEA/DSV/i2BM/SHFJ, 91401 Orsay, France.
N. Blanchin
Affiliation:
CEA/SMT Cadarache, 13108 Saint-Paul-lez-Durance, France.
L. Grappin
Affiliation:
CEA/SMT Cadarache, 13108 Saint-Paul-lez-Durance, France.
E. Blanchardon
Affiliation:
IRSN/DRPH/SDI/LEDI, BP 17, 92262 Fontenay-aux-Roses Cedex, France.
B. Breustedt
Affiliation:
FZK/GmbH, PO Box 3640, 76021 Karlsruhe, Allemagne.
J.-L. Poncy
Affiliation:
Laboratoire de Radiotoxicologie, CEA/DSV/iRCM/SREIT, BP 12, 91680 Bruyères-le-Châtel, France.
Get access

Abstract

Un nouvel outil a été développé pour optimiser l’efficacité des traitements par le DTPA après blessure, sur la base d’une réduction de la dose efficace engagée. Les simulations montrent, notamment, que pour du 239Pu modérément soluble (type M), des traitements précoces (24 i.v.) étalées sur 4 mois permettent une réduction d’un tiers de la dose, alors que leur prolongement sur 5 ans, avec un intervalle de 2 semaines, peut diminuer la dose d’un facteur 5. En revanche, pour des composés peu solubles (type S), l’efficacité des traitements précoces est négligeable et un gain dosimétrique d’un facteur 3 n’est atteint que pour des traitements effectués 2 fois par mois durant 50 ans. Certaines des hypothèses retenues pour la modélisation ont été validées par les résultats d’expérimentations animales récemment publiés. Enfin, la structure d’un nouveau modèle applicable à la fois au Pu et à l’Am est rapportée, structure tenant compte de la décorporation urinaire et fécale de ces actinides et qui pourrait être adapté à différentes posologies et formes galéniques de DTPA.

Keywords

DTPAplutoniumamericiuminhalationwound
Type
Research Article
Information
Radioprotection , Volume 44 , Issue 4 , October 2009 , pp. 431 - 446
Copyright
© EDP Sciences, 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ansoborlo, E., Prat, O., Moisy, P., Den Auver, C., Guilbaud, P., Carriere, M., Gouget, B., Duffield, J., Doizi, D., Vercouter, T., Moulin, C., Moulin, V. (2006) Actinide speciation in relation with biological processes, Biochimie 88, 1605-1618. CrossRef
Bhattacharyya M.H., Breitenstein B.D., Métivier H., Muggenburg B.A., Stradling G.N., Volf V. (1992) Guidebook for the treatment of accidental internal contamination of workers, Nuclear Technology Publishing, Ashford.
Breustedt, B., Blanchardon, E., Fritsch, P., Giussani, A., Lopez, M.A., Luciani, A., Malatova, I., Nosske, D., Piechowski, J., Schimmelpfeng, J., Sérandour, A.-L. (2009) Biokinetic modeling of DTPA decorporation therapy: the CONRAD approach, Radiat. Prot. Dosim. 134, 38-48. CrossRef
FDA (2002) Food and Drug Administration, Guidance for industry on pentetate calcium trisodium and pentetate zinc trisodium for treatment of internal contamination with plutonium, americium or curium; availability, Federal Register 68, 53984-53988.
Fritsch, P., Grappin, L., Guillermin, A.M., Fottorino, R., Ruffin, M., Mièle, A. (2007) Modelling of bioassay data from a Pu wound treated by repeated DTPA perfusions: biokinetics and dosimetric approaches, Radiat. Prot. Dosim. 127, 120-124. CrossRef
Fritsch, P., Sérandour, A.L., Grémy, O., Phan, G., Tsapis, N., Abram, M.C., Renault, D., Fattal, E., Benech, H., Deverre, J.R., Poncy, J.L. (2009a) Simplified structure of a new model to describe urinary excretion of Pu after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments, Radiat. Res. 171, 674-686. CrossRef
Fritsch P., Sérandour A.L., Grémy O., Phan G., Tsapis N., Fattal E., Benech H., Deverre J.R., Poncy J.L. (2009b) Structure of a single model to describe plutonium and americium decorporation by DTPA treatment, Health Phys. (soumis).
Gervelas, C., Sérandour, A.L., Geiger, S., Grillon, G., Fritsch, P., Taulelle, C., Le Gall, B., Benech, H., Deverre, J.R., Fattal, E., Tsapis, N. (2007) Direct lung delivery of a dry powder formulation of DTPA with improved aerosolization properties: effect on lung and systemic decorporation of plutonium, J. Control. Release 118, 78-86. CrossRef
Grappin, L., Bérard, P., Ménétrier, F., Carbone, L., Courtray, C., Castagneux, X., Le Golf, J.P., Neron, M.O., Piechowski, J. (2007) Treatment of actinide exposures: a review of Ca-DTPA injections inside CEA-COGEMA plants, Radiat. Prot. Dosim. 127, 435-439. CrossRef
Grappin, L., Bérard, P. (2008) Autorisation de mise sur le marché du Ca-DTPA, Radioprotection 43, 465-466. CrossRef
Grappin, L., Legoff, J.P., Carbone, L., Courtay, C., Agrinier, A.L., Animat, M., Amabile, J.C., Florin, A., André, F. (2009) Traitement par le Ca-DTPA des contaminations internes par plutonium et américium : Recommandations pour la rédaction de protocoles dans les centres CEA et AREVA, Radioprotection 44, 447-461. CrossRef
Hengé-Napoli, M.H., Stradling, G.N., Taylor, D.M. (2000) Decorporation of radionuclides from the human body, Radiat. Prot. Dosim. 87, 11.
IUPAC (2004) Stability constants database, Academic Software, Timble, U.K.
James, A.C., Sasser, L.B., Stuit, D.B., Glover, S.E., Carbaugh, E.H. (2007) USTUR whole body case 0269: demonstrating effectiveness of I.V. Ca-DTPA for Pu, Radiat. Prot. Dosim. 127, 114-119. CrossRef
Leggett, R.W., Eckerman, K.F., Khokhryakov, V.F., Suslova, K.G., Krahenbuhl, M.P., Miller, S.C. (2005) Mayak worker study: an improved biokinetic model for reconstructing doses from internally deposited plutonium, Radiat. Res. 164, 111-122. CrossRef
Ménétrier, F., Grappin, L., Raynaud, P., Courtay, C., Wood, R., Joussineau, S., List, V., Stradling, G.N., Taylor, D.M., Bérard, P., Morcillo, M.A., Rencova, J. (2005) Treatment of accidental intakes of plutonium and americium: guidance notes, Appl. Radiat. Isot. 62, 829-846. CrossRef
Mièle A., Blanchin N., Raynaud P., Quesne B., Giraud J.M., Fottorino R., Bérard P., Ansoborlo E., Franck D., Blanchardon E., Challeton-de Vathaire C., Lebaron-Jacobs L., Poncy J.L., Piechowski J., Fritsch P. (2007) MEDOR, a didactic tool to support interpretation of bioassay data after internal contamin Radiat. Prot. Dosim. 127, 350-355. CrossRef
Roedler, H.D., Nobke, D., Ohlenschäger, L., Schieferdecker, H., Doerfel, H., Renz, K. (1989) Incorporation of 241Am: effectiveness of late chelation therapy, Radiat. Prot. Dosim. 26, 377-379. CrossRef
Sérandour, A.L., Grémy, O., Fréchou, M., Renault, D., Poncy, J.L., Fritsch, P. (2008) In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early DTPA treatment, Radiat. Res. 170, 208-215. CrossRef
Sérandour, A.L., Fritsch, P. (2008) Pulmonary retention of actinides after dissolution of PuO2 aerosols: interest in modelling DTPA decorporation, Radioprotection 43, 239-254. CrossRef
Stather, J.W., Stradling, G.N., Gray, S.A., Moody, J., Hodgson, A. (1985) Use of DTPA for increasing the rate of elimination of plutonium-238 and americium-241 from rodents after their inhalation as the nitrates, Hum. Toxicol. 4, 573-582. CrossRef
Stradling, G.N., Stather, J.W., Sumner, S.A., Strong, J.C., Lennox, A.M., Ham, S.E. (1984) Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA, Health Phys. 46, 919-924.
Taylor, D.M., Hodgson, S.A., Stradling, N. (2007) Treatment of human contaminations with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective? Radiat. Prot. Dosim. 127, 469-471. CrossRef
Turner, G.A., Taylor, D.M. (1968) The transport of plutonium, americium and curium in the blood of rats, Phys. Med. Biol. 13, 535-546. CrossRef
Tymen, H., Schoulz, D., Caire-Maurisier, A.M., Chevrier, F., Curet, P.M. (2000) Emergency treatment of pulmonary contaminations by transuranium elements. A new galenic form of Na3CaDTPA, Radioprotection 35, 473-485. CrossRef